Life Sciences Newsbrief – November 2011, Issue #37

Welcome to PwC’s monthly issue of the Life Sciences Newsbrief. This publication provides you with a snapshot of developments in the Canadian and global life sciences industry along with upcoming Canadian events and thought leadership. If you need further information, please contact any of the life sciences professionals listed on the right.

Thought Leadership

How the Jenkins report can positively shape the future of Canada’s Life Sciences Industry: PwC's Perspective

The Jenkins report "Innovation Canada: A Call to Action" released last month provided recommendations on maximizing the effect of federal programs that contribute to innovation and create economic opportunities for business. While the report did not contain specific recommendations in respect of any particular industry sectors, there is no doubt the report could have a significant impact on Canada’s life science industry depending on how the federal government implements some or all of the recommendations.

To get suggestions for starting a consensus on how the Jenkins report’s recommendations can be favourably implemented for the life sciences sector, read “How the Jenkins report can positively shape the future of Canada’s Life Sciences Industry,” an article by Gord Jans, our Pharmaceuticals and Life Sciences leader. To read PwC’s summary of the Jenkins report and what adoption of the report recommendations may mean for the industry, click here.

Events

2011 Bohemian European Medical Device CEO Summit
December 7-9, Budapest, Hungary
PwC is a sponsor of this invitation-only conference for senior executives from medical device companies in Europe. This conference provides a private and exclusive setting for networking and partnering. The agenda will include high-level panel discussions with keynotes from industry and academic leaders, as well as social networking events. Tracy Lefteroff, PwC's US National Life Sciences partner, will moderate the last session of the conference on exit strategies.